Literature DB >> 144359

[Enzyme histochemical, histometrical and ultrastructural studies of spleens in vinylchloride-disease (author's transl)].

U Heusermann, H J Stutte.   

Abstract

By means of histometric, enzyme histochemical, and electron microscopic investigations it was demonstrated that the pathological changes in the spleen in vinylchloride-disease are primary. Fibroblastic cells are the only specific splenic cells involved. Fibre-associated reticulum cells of the red pulp and fibroblastic reticulum cells in white pulp are stimulated to produce excessive amounts of the extracellular elements of connective tissue, especially collagen fibrils. The newly formed connective tissue causes obliteration of extracellular blood channels in the red pulp and thus a reduction in the number of pulp-cord macrophages, and scarring of the periaterial lymphatic sheaths. The results of this fibrosing process are characteristic quantitative changes in the splenic histologic structures. These changes are different from those structural alterations occurring in spleens following extrasplenic hemodynamic changes, such as thrombosis of the splenic veins or cirrhosis of the liver.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 144359     DOI: 10.1007/bf00427061

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  12 in total

1.  Unusual splenomegalic liver disease as evidenced by peritoneoscopy and guided liver biopsy among polyvinyl chloride production workers.

Authors:  H J Marsteller; W K Lelbach; R Müler; P Gedigk
Journal:  Ann N Y Acad Sci       Date:  1975-01-31       Impact factor: 5.691

2.  Clinical manifestations and course of vinyl chloride disease.

Authors:  G Veltman; C E Lange; S Jühe; G Stein; U Bachner
Journal:  Ann N Y Acad Sci       Date:  1975-01-31       Impact factor: 5.691

3.  Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to Angiosarcomas.

Authors:  L B Thomas; H Popper; P D Berk; I Selikoff; H Falk
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

4.  Alterations of liver and spleen among workers exposed to vinyl chloride.

Authors:  H Popper; L B Thomas
Journal:  Ann N Y Acad Sci       Date:  1975-01-31       Impact factor: 5.691

5.  Collagen studies in acro-osteolysis.

Authors:  M I Jayson; A J Bailey; C Black; K L Jones
Journal:  Proc R Soc Med       Date:  1976-04

6.  Vinyl chloride-associated liver disease.

Authors:  P D Berk; J F Martin; R S Young; J Creech; I J Selikoff; H Falk; P Watanabe; H Popper; L Thomas
Journal:  Ann Intern Med       Date:  1976-06       Impact factor: 25.391

7.  Intercellular junctions of sinus lining cells in the human spleen.

Authors:  U Heusermann; H J Stutte
Journal:  Cell Tissue Res       Date:  1974       Impact factor: 5.249

8.  [Vinyl chloride disease (author's transl)].

Authors:  C E Lange; S Jühe; G Stein; G Veltman
Journal:  Int Arch Arbeitsmed       Date:  1974

9.  [Chronic toxic liver lesions in the PVC (polyvinyl chloride)-producing workers].

Authors:  H J Marsteller; W K Lelbach; R Müller; S Jühe; C E Lange; H G Rohner; G Veltman
Journal:  Dtsch Med Wochenschr       Date:  1973-11-30       Impact factor: 0.628

10.  Pathology of angiosarcoma of the liver among vinyl chloride-polyvinyl chloride workers.

Authors:  L B Thomas; H Popper
Journal:  Ann N Y Acad Sci       Date:  1975-01-31       Impact factor: 5.691

View more
  3 in total

1.  [Aetiology of the thrombocytopenia in vinylchloride disease (author's transl)].

Authors:  U Heusermann; H J Stutts
Journal:  Blut       Date:  1977-09-18

2.  Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology.

Authors:  H Popper; L B Thomas; N C Telles; H Falk; I J Selikoff
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

3.  Association of alkaline-phosphatase-positive reticulum cells in bone marrow with granulocytic precursors.

Authors:  H Westen; D F Bainton
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.